C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2004
11/25/2004	US20040235006 Chemical compounds
11/25/2004	US20040234993 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
11/25/2004	US20040234990 Method of screening alzheimer's disease-associated gene
11/25/2004	US20040234959 Truncated bard1 protein, and its diagnostic and therapeutic uses
11/25/2004	US20040234953 Viral nucleotide sequences coding envelope proteins for use in preparing antibodies for prevention and treatment of autoimmune disorders
11/25/2004	US20040234537 Quantitative, qualitative analysis of peptide; monitoring concentration in human tissue of monoclonal antibody; calibration
11/25/2004	US20040234536 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
11/25/2004	US20040234531 Autoimmune disease; antidiabetic agents; protein
11/25/2004	US20040234530 Plasmid-specific polypeptide found in Eschericha; diagnosis of infections; induction of immunology response
11/25/2004	US20040234529 Helicobacter pylori adhesin binding group antigen
11/25/2004	US20040234528 Binding, neutralization respiratory syncytial virus antigen
11/25/2004	US20040234527 Peptides for use as translocation factors
11/25/2004	US20040234526 Use of a compound antagonist of esm-1 protein for producing a medicine for treating cancer
11/25/2004	US20040234525 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction
11/25/2004	US20040234524 Anti-osteopontin antibody and use thereof
11/25/2004	US20040234521 Antigen detection segments; crosslinking receptors
11/25/2004	US20040234520 Uses for Eph receptor antagonists and agonists
11/25/2004	US20040234519 Neutralization of pleiotropin; anticancer agents ; angiogenesis inhibitors
11/25/2004	US20040234518 Composition, methods and reagents for the synthesis of a soluble form of human PHEX
11/25/2004	US20040234499 Asthma-related anti-IL-13 immunoglobulin derived proteins, compositions, methods and uses
11/25/2004	US20040234498 Inducing apoptosis in mammalian cancer cellsl stimulanting a proinflammatory response ; polypeptides; tumor necrosis factor
11/25/2004	CA2525899A1 Ovr110 antibody compositions and methods of use
11/25/2004	CA2525870A1 Liver x receptor .alpha. splicing mutant protein, gene thereof and use thereof
11/25/2004	CA2525766A1 Method for selecting and producing vaccine components and vaccines based thereon
11/25/2004	CA2525370A1 Domain-exchanged binding molecules, methods of use and methods of production
11/25/2004	CA2525120A1 A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
11/25/2004	CA2523001A1 Therapeutic use of anti-cs1 antibodies
11/24/2004	EP1480041A1 Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease
11/24/2004	EP1479773A1 Mite galectin
11/24/2004	EP1479771A2 Method to screen phage display libraries with different ligands
11/24/2004	EP1479768A1 Novel screening method
11/24/2004	EP1479697A1 Tick chitinase
11/24/2004	EP1479696A1 Human monoclonal antibody binding Ep-CAM, and its use in cancer therapy
11/24/2004	EP1479695A1 Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS O6 of Pseudomonas aeruginosa
11/24/2004	EP1479694A2 Intrabodies ScFv with defined framework that is stable in a reducing environment
11/24/2004	EP1479693A1 Egf/egfr complex
11/24/2004	EP1479692A1 Peptides responsive to antibodies against a consensus peptide of the CS4-CFA/I family proteins
11/24/2004	EP1478927A2 Macromolecular conjugates and processes for preparing same
11/24/2004	EP1478923A2 Assay for anti-ingap antibodies
11/24/2004	EP1478777A2 Sequences specifically deleted from mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
11/24/2004	EP1478769A2 Phytases, nucleic acids encoding them and methods for making and using them
11/24/2004	EP1478764A2 Humanized collagen antibodies and related methods
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478758A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
11/24/2004	EP1478753A1 Genetic sequences having methyltransferase activity and uses therefor
11/24/2004	EP1478751A2 Avian lysozyme promoter
11/24/2004	EP1478748A2 Fce fusion proteins for treatment of allergy and asthma
11/24/2004	EP1478745A2 Kinases and phosphatases
11/24/2004	EP1478740A2 Heteromultimeric tnf ligand family members
11/24/2004	EP1478738A1 Anti-ccr5 antibody
11/24/2004	EP1478667A1 Anti-human tenascin monoclonal antibody
11/24/2004	EP1478381A2 Use of soluble gamma delta t cell receptors for regulating t cell function
11/24/2004	EP1392859A4 Isolating cells expressing secreted proteins
11/24/2004	EP1390503A4 Novel nucleic acid molecules
11/24/2004	EP1303539B1 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
11/24/2004	EP1238279B1 Helicobacter pylori antigens in blood
11/24/2004	EP1049787B1 Multipurpose antibody derivatives
11/24/2004	EP1007677B1 Protease-related protein
11/24/2004	EP0998493B1 Epitopes of shigella like toxin and their use as vaccine and in diagnosis
11/24/2004	EP0981546A4 Protein smi on hematopoietic stem cells
11/24/2004	EP0951481B1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
11/24/2004	EP0783317B1 Mimetics of senescent cell derived inhibitors of dna synthesis
11/24/2004	EP0745129B1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
11/24/2004	EP0656012B1 T cell epitopes of ryegrass pollen allergen
11/24/2004	CN1549826A Compositions and methods of treating diabetes
11/24/2004	CN1549821A A system for antibody expression and assembly
11/24/2004	CN1549723A Modified interleukin-1 receptor antagonist (IL-1RA) with reduced immunogenicity.
11/24/2004	CN1177052C Human growth factor variation spliceosome protein and coding sequence thereof
11/24/2004	CN1177050C Coding polynucleotide of human protein with function of suppressing cancer cell growth
11/24/2004	CN1177049C Coding polynucleotide of human protein with function of suppressing cancer cell growth
11/24/2004	CN1177048C Coding polynucleotide of human protein with function of suppressing cancer cell growth
11/24/2004	CN1177047C Coding polynucleotide of human protein with cancer suppressing function
11/24/2004	CN1176948C Single-chain antibody resisting HIV-1 outer membrane protein and recombinant immunotoxin
11/23/2004	US6822141 Diacylglycerol acyl transferase proteins
11/23/2004	US6822083 TSA305 gene
11/23/2004	US6822080 For identification/cloning/drug screening; enzyme inhibitors
11/23/2004	US6822078 Compounds for use in the evaluation of humans inflammatory and immunological defects
11/23/2004	US6822076 Hybrid ptorin for use in treating allergies and controlling immunogical response
11/23/2004	US6822075 Protein for use in the diagnosis and treatment of autoimmune, cancer and viral disorders
11/23/2004	US6822072 For diagnostics/forensics/gene therapy/chromosome mapping; expression vector design/secretion
11/23/2004	US6821945 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
11/23/2004	US6821767 Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions
11/23/2004	US6821754 Staphylococcus aureus genes and polypeptides
11/23/2004	US6821731 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis of prostate cancer
11/23/2004	US6821725 Methods for the diagnosis and treatment of breast cancer
11/23/2004	US6821519 Comprises polypeptide for detecting viral infection; immunoassays; immunostimulant
11/23/2004	US6821517 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
11/23/2004	US6821515 Protein formulation
11/23/2004	US6821505 Composition comprising a mutant igg molecule having an increased serum half-life relative to igg, and wherein said mutant igg molecule has at least one amino acid substitution in the fc-hinge region
11/23/2004	CA2260835C Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
11/23/2004	CA2116026C Hepatitis c assay utilizing recombinant antigens to c-100 region
11/23/2004	CA2012482C Hepatitis c diagnostics and vaccines
11/18/2004	WO2004099784A2 Method for determining a tissue degradation process by detection of fibromodulin neoepitopes
11/18/2004	WO2004099775A1 Means for detecting protein conformation and applications thereof
11/18/2004	WO2004099418A1 Fused protein
11/18/2004	WO2004099410A2 Compound and method for regulating plasminogen activation and cell migration
11/18/2004	WO2004099376A2 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
11/18/2004	WO2004099374A2 Methods for recombinant immunoglobulin treatment
11/18/2004	WO2004099253A1 Method of detecting probnp with a monoclonal antibody binding to the amino acid 41-46
11/18/2004	WO2004099252A1 Method of detecting native probnp with amonoclonal antibody binding to the amino acids 38-44

1 ... 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 ... 1494